SEENA SUNNY: Open Payments
NPI 1164283818 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 40 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $73 · 2025 $997
Food & beverage: $991Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $267 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $223 |
| Alkermes, Inc. | 3 | $86 |
| ABBVIE INC. | 4 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
Products named: INVEGA SUSTENNA, CAPLYTA, VRAYLAR, INGREZZA, FANAPT, REXULTI, ARISTADA, COBENFY.
Industry payments across AZ — which companies pay providers there.
